TE
EW icon

Tema ETFs’s Edwards Lifesciences EW Stock Holding History

Tema ETFs’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Sell
19,353
-2,300
-11% -$193K 0.06% 200
2026
Q1 		$1.73M Buy
21,653
+1,706
+9% +$141K 0.12% 161
2025
Q4 		$1.7M Sell
19,947
-2,401
-11% -$197K 0.13% 168
2025
Q3 		$1.74M Buy
22,348
+7,927
+55% +$619K 0.14% 179
2025
Q2 		$1.13M Sell
14,421
-2,122
-13% -$158K 0.3% 101
2025
Q1 		$1.2M Sell
16,543
-5,092
-24% -$364K 0.36% 83
2024
Q4 		$1.6M Buy
+21,635
New +$1.51M 0.67% 45

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
NO
Ninety One Cape Town, South Africa $1.85B AUM 62.46% 1-Year Est. Return

Tema ETFs's EW Position: Q2 2026 in Review

Tema ETFs reduced its Edwards Lifesciences (EW) stake by 11% in Q2 2026, selling an estimated $193K and leaving 19,353 shares worth $1.75M. The position accounts for 0.06% of the portfolio, ranked #200.

Tema ETFs first reported a position in EW in Q4 2024 and has held it in 7 quarters since. 195 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Tema ETFs held 19,353 shares of Edwards Lifesciences worth $1.75M as of Q2 2026.
  • Tema ETFs sold 2,300 Edwards Lifesciences shares in Q2 2026, an estimated $193K.
  • Edwards Lifesciences made up 0.06% of Tema ETFs's portfolio in Q2 2026, its #200 holding.
  • Tema ETFs first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 7 quarters since.
  • 195 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Tema ETFs's 13F filing for Q2 2026, filed 10 Jul 2026.